STLN
The Oncology Institute, Inc.
6.30$
-2.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.4% | 81.6% | 86.3% | 84.8% | |
| 20.6% | 18.4% | 13.7% | 15.2% | |
| 47.4% | 35.1% | 27.4% | 21.0% | |
| 128.5% | 118.6% | 115.3% | 22.4% | |
| -28.5% | -18.6% | -15.3% | -7.2% | |
| 1.6% | 2.1% | 1.9% | 2.2% | |
| 0.0% | -25.6% | -16.4% | -12.1% | |
| – | – | – | 0.0% | |
| 0.1% | -25.6% | -16.4% | -12.1% | |
| – | – | – | -8.5% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.